NJV
5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methyl-N-{6-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]pyridin-2-yl}benzamide
Find entries where: NJV
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methyl-N-{6-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]pyridin-2-yl}benzamide |
Synonyms | Selonsertib; GS-4997 |
Identifiers | 5-(4-cyclopropylimidazol-1-yl)-2-fluoranyl-4-methyl-~{N}-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridin-2-yl]benzamide |
Formula | C24 H24 F N7 O |
Molecular Weight | 445.492 |
Type | NON-POLYMER |
Isomeric SMILES | Cc1cc(c(cc1n2cc(nc2)C3CC3)C(=O)Nc4cccc(n4)c5nncn5C(C)C)F |
InChI | InChI=1S/C24H24FN7O/c1-14(2)32-13-27-30-23(32)19-5-4-6-22(28-19)29-24(33)17-10-21(15(3)9-18(17)25)31-11-20(26-12-31)16-7-8-16/h4-6,9-14,16H,7-8H2,1-3H3,(H,28,29,33) |
InChIKey | YIDDLAAKOYYGJG-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 57 |
Chiral Atom Count | 0 |
Bond Count | 61 |
Aromatic Bond Count | 22 |
Drug Info: DrugBank
DrugBank ID | DB14916 |
---|---|
Name | Selonsertib |
Groups | investigational |
Description | Selonsertib is under investigation in clinical trial NCT03053050 (Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis). |
Synonyms |
|
Categories |
|
CAS number | 1448428-04-3 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL3916717 |
PubChem | 71245288 |
ChEMBL | CHEMBL3916717 |